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Terpendole E is the first natural product inhibitor of
kinesin Eg5. Because terpendole E production is
unstable, we isolated and analyzed the terpendole E
biosynthetic gene cluster, which consists of seven
genes encoding three P450 monooxygenases (TerP,
TerQ, andTerK), an FAD-dependentmonooxygenase
(TerM), a terpenecyclase (TerB), and twoprenyltrans-
ferases (TerC and TerF). Gene knockout and feeding
experiments revealed that terpendole E is a key
intermediate in terpendole biosynthesis and is pro-
duced by the action of the key enzyme TerQ from
paspaline, a common biosynthetic intermediate of
indole-diterpenes. TerP converts terpendole E to
a downstream intermediate specific to terpendole
biosynthesis and converts paspaline to shuntmetab-
olites. We successfully overproduced terpendole E
by disrupting the terP gene. We propose that terpen-
dole E is a key biosynthetic intermediate of terpen-
doles and related indole-diterpenes.
INTRODUCTION
The kinesin Eg5 is required for the separation of centrosomes
during mitosis. Thus, Eg5 inhibitors can arrest the cell cycle of
cancer cells at the M phase. Eg5 inhibitors are expected to be
potent anticancer drugs with fewer side effects than conven-
tional mitotic inhibitors that directly inhibit polymerization of
microtubules (Knight and Parrish, 2008; Sarli and Giannis,
2008). Terpendole E (1) (Figure 1A) is the first described kinesin
Eg5 inhibitor of natural product origin (Nakazawa et al., 2003),
but it is produced transiently and is difficult to isolate. Therefore,
elucidation of the biosynthetic mechanism is important to be
able to produce adequate quantities of terpendole E (1) and to
isolate new analogs with potent biological activity.
Terpendole E (1) is an indole-diterpene secondary metabolite
produced by the Ascomycota fungus Chaunopycnis alba
(Albophoma yamanashiensis). Some indole-diterpenes are
tremorgenic mycotoxins that are produced to control insect
and mammalian predators. Indole-diterpenes are produced
from several Ascomycota filamentous fungi belonging to the
evolutionarily separated Eurotiomycetes and Sordariomycetes
groups (Saikia et al., 2008); C. alba belongs to the Sordariomy-Chemistry & Biology 19, 1611–161cetes class of fungi. Analysis of indole-diterpene biosynthetic
gene clusters in four filamentous fungi—Penicillium paxilli (paxil-
line (2) producer, Eurotiomycetes), Aspergillus flavus (aflatrem (3)
producer, Eurotiomycetes), Neotyphodium lolii (lolitrem B (4)
producer, Sordariomycetes), and Epichloe¨ festucae (lolitrem B
(4) producer, Sordariomycetes)—revealed the presence of
similar biosynthetic pathways (Figures 1A and 1B) (Saikia et al.,
2008; Young et al., 2001, 2005; Zhang et al., 2004). In the paxil-
line (2) biosynthetic gene cluster of P. paxilli (Figure 1B), four
proteins (PaxG, PaxC, PaxM, and PaxB) are involved in the
biosynthesis of paspaline (6), the first detectable intermediate
in paxilline biosynthesis. Paspaline (6) is converted to 13-des-
oxypaxilline (7) by a P450 enzyme PaxP, and 13-desoxypaxilline
(7) is then converted to paxilline (2) by another P450 enzyme,
PaxQ. A. flavus, N. lolii, and E. festucae also have homologs of
the six Pax enzymes, suggesting that the four filamentous fungi
share similar indole-diterpene biosynthetic pathways. Terpen-
dole E (1) and paspaline (6) have similar structures (Figures 1A
and 1B); thus, we propose that terpendole E (1) is biosynthesized
by C11 hydroxylation of the common intermediate, paspaline (6).
Despite the possibility that terpendole E (1) could be a biosyn-
thetic intermediate in indole-diterpene biosynthesis, it has not
been isolated from the other indole-diterpene producers,
although N. lolii produces a terpendole E-like compound lolicine
A (5) (Figure 1A). This observation suggests that the indole-
diterpene biosynthetic pathways may differ between Sordario-
mycetes (C. alba, N. lolii, and E. festucae) and Eurotiomycetes
(P. paxilli and A. flavus).
Here, we isolated a biosynthetic gene cluster for terpendole
E (1) and analyzed the biosynthetic pathway in C. alba. The
results show that terpendole E (1) is an important intermediate
in indole-diterpene biosynthesis in this fungal species. More-
over, we demonstrate that terpendole E (1) can be overproduced
by disrupting terP, which encodes a PaxP homolog that is
involved in conversion of terpendole E (1) to its downstream
intermediates.RESULTS
Isolation of the Terpendole E (1) Biosynthetic Gene
Cluster
The homolog of the paxP gene was amplified by degenerate
PCR from genomic DNA of the terpendole E (1) producer
RK99-F33. The amplified 0.5 kb PCR product was cloned and
sequenced. The deduced amino acid sequence of the partial
putative terP product, TerP, showed high similarity to the P4509, December 21, 2012 ª2012 Elsevier Ltd All rights reserved 1611
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Figure 1. Terpendole E (1) Is an Indole-
Diterpene Compound with Similarity to
Paspaline (6) and Lolicine A (5)
(A) Terpendole E (1) and related indole-diterpene
compounds.
(B) The paxilline (2) biosynthetic pathway.
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Terpendole Biosynthetic Gene Clustermonooxygenase PaxP (45%) and the PaxP orthologs AtmP
(45%) and LtmP (66%). A 25 kb region around the 0.5 kb
fragment of terP was cloned by genome walking and was
sequenced. This region contained ten putative genes (Figure 2A;
Table S1 available online). All ten putative genes showed high
similarity to Sordariomycetes genes. Seven genes (terK, terC,
terB, terQ, terM, terP, and terF) showed high similarity to
indole-diterpene biosynthetic genes. The remaining three genes
(orf1, orf2, and orf3) showed high similarity to genes involved in
primary metabolism. Indole-diterpene biosynthetic gene clus-
ters have previously been analyzed in four filamentous fungi.
The deduced amino acid sequences of the seven gene products
isolated here showed highest similarity to homologs from a loli-
trem B (4) producer N. lolii (LtmK, 54%; LtmC, 55%; LtmB,
70%; LtmQ, 61%; LtmM, 49%; LtmP, 61%; and LtmF, 54%).
terP Knockout Strains Accumulate Terpendole E (1)
In P. paxilli, PaxP is required for the metabolism of paspaline (6).
Because paspaline (6) and terpendole E (1) have very similar
structures (Figures 1A and 1B), we predicted that the PaxP
homolog TerP would metabolize terpendole E (1) and that
terpendole E (1) could be overproduced by knocking out terP.
To test this, the terP gene was disrupted by Agrobacterium
tumefaciens-mediated transformation. All the terP knockout
strains analyzed (P-9, P-18, and P-27) accumulated terpendole
E (1) (Figure 2B, data for P-27 are shown). The P-27 strain accu-
mulated 36 mg/l terpendole E (1) after 2 days. In contrast, the
wild-type strain accumulated terpendole E (1) only transiently
on day 1 (2.5 mg/l) and predominantly accumulated terpendole
I (8), terpendole K (9), and terpendole C (10) (see Figure 6 for1612 Chemistry & Biology 19, 1611–1619, December 21, 2012 ª2012 Elsevier Ltd All rights rchemical structures). These data indicate
that terP is involved in the biosynthesis
of terpendoles and that terpendole E (1)
is either a biosynthetic intermediate or
a shunt metabolite from another biosyn-
thetic intermediate.
Terpendole E (1) Is a Biosynthetic
Intermediate in Indole-Diterpene
Biosynthesis
To determine whether terpendole E (1) is
a biosynthetic intermediate in indole-
diterpene biosynthesis and is converted
to other biosynthetic intermediates, we
constructed a C. alba strain (DGC+P-48)
in which all ter genes except terP were
deleted (Figure 3). As controls, we con-
structed strains (DGC-2 and DGC-3)
in which all seven ter genes were deleted
(Figure 3) and strains (DGC+Q-3 andDGC+Q-5) in which all ter genes except terQ (another P450
gene) were deleted (Figure 3A). These strains were defective in
terpendole production (data not shown), confirming that this
gene cluster is essential for terpendole biosynthesis. These
strains were next used for feeding experiments (Figure 4). The
DGC+P-48 strain converted terpendole E (1) to another
compound (Figure 4A). In contrast, the DGC-2 strain and the
DGC+Q-3 strain did not metabolize terpendole E (1). The terpen-
dole E (1) metabolite was isolated from theDGC+P-48 strain, and
its structure was determined. The observedmass was 437.2570,
and the chemical formula C27H35O4N (437.2566) was predicted.
NMRanalysis (Figure S1; Table S2) indicated that this compound
is a new, to our knowledge, terpendole I derivative, 13-desoxy-
terpendole I (Figure 6, compound 11). The DGC+Q-3 strain
converted 13-desoxyterpendole I (11) to terpendole I (8) (Fig-
ure 4B). Terpendole I (8) is proposed to be a biosynthetic
intermediate of terpendole C (10) (Young et al., 2009). Our data
thus indicate that terpendole C (10) is biosynthesized via
terpendole E (1).
13-Desoxypaxilline (7) Is Not a Biosynthetic
Intermediate in Terpendole Biosynthesis
13-Desoxypaxilline (7) is a biosynthetic intermediate of paxilline
(2) and aflatrem (3) (Nicholson et al., 2009; Saikia et al., 2007)
and is proposed to be a biosynthetic intermediate of lolitrem B
(4) and terpendole C (10) (Li, 2010; Young et al., 2009). The
DGC+P-48 strain was able to convert paspaline (6) to 13-des-
oxypaxilline (7), a-PC-M6 (12), and a putative 13-desoxypaxilline
analog (13) with +16 mass of 13-desoxypaxilline (7) (Figure 4C;
see Figure 6 for chemical structure of 12). The DGC+P-48 straineserved
P450 P450 P450PT PTOXYTC
terK
2 kb
terC terB terM terPterQ terF
16 kb terpendole biosynthetic gene cluster
orf1 orf2 orf3
A
B
Wild type P-27 ( terP)
1 d
2 d
3 d
-0.05 
0.3 
0.65 
22 24 26 28 30 32 34 36 
-0.05 
0.5 
1.05 
22 24 26 28 30 32 34 36 
-0.05 
0.3 
0.65 
22 24 26 28 30 32 34 36 
-0.05 
0.5 
1.05 
22 24 26 28 30 32 34 36 
-0.05 
0.3 
0.65 
22 24 26 28 30 32 34 36 
-0.05 
0.5 
1.05 
22 24 26 28 30 32 34 36 
1
1
1
time (min)time (min)
18
8
8
9
9
10
10
Figure 2. Isolation of the Terpendole Biosynthetic Gene Cluster
(A) Terpendole biosynthetic gene cluster. Genes with similarity to known indole-diterpene biosynthetic genes are shaded.
(B) A terP knockout strain (P-27) accumulates terpendole E (1). The wild-type and P-27 strains were cultured in FDY for 1–3 days, and cultures were analyzed by
HPLC. Terpendoles were detected by absorbance at 280 nm. For further details, see Tables S1 and S3.
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Terpendole Biosynthetic Gene Clusteralso converted a-PC-M6 (12) to 13-desoxypaxilline (7) (Fig-
ure 4D), suggesting that TerP converts paspaline (6) to 13-
desoxypaxilline (7) via a-PC-M6 (12). The DGC+Q-3 strain
metabolized a-PC-M6 (12) to some unidentified compounds
(Figure 4D) and also metabolized 13-desoxypaxilline (7) to paxil-
line (2) and to an unidentified compound (14) with +14 mass of
13-desoxypaxilline (7) (Figure 4E). However, the DGC+Q-3 strain
did not convert a-PC-M6 (12) or 13-desoxypaxilline (7) to the
pathway intermediates 13-desoxyterpendole I (11) or terpendole
I (8) (Figures 4D and 4E). Our data therefore indicate that 13-des-
oxypaxilline (7) is a shunt metabolite in terpendole biosynthesis.
Terpendole E (1) Is Biosynthesized fromPaspaline (6) via
C11 Hydroxylation by TerQ
Because PaxQ catalyzes C13 hydroxylation of paspaline, we
hypothesized that the paspaline C11-hydroxylating enzyme is
TerQ, a PaxQ homolog. If this hypothesis is true, we reasoned
that a terQ knockout strain should accumulate paspaline (6).
To test this, we constructed the terQ knockout strains Q-10
and Q-102 and found that neither strain could produce terpen-
dole E (1) (Figure 5), indicating that TerQ is a C11-hydroxylating
enzyme. The terQ knockout strains accumulated paspaline (6),
but this gradually decreased, and 13-desoxypaxilline (7) accu-
mulated as the major product, suggesting that paspaline (6)
has been converted to 13-desoxypaxilline (7). a-PC-M6 (12)
and a putative 13-desoxypaxilline analog (13) also accumulated
in the terQ knockout strains. These products were predicted to
be converted by TerP because PaxP is known to convert paspa-Chemistry & Biology 19, 1611–161line (6) to 13-desoxypaxilline (7) (Figure 1B). To prove this, we
constructed terP/terQ double-knockout strains (PQ-2 and
PQ-4) by disrupting the terQ gene in the terP disruptant P-27.
As predicted, PQ-2 and PQ-4 accumulated paspaline (6) without
producing 13-desoxypaxilline (7) (Figure 5), suggesting that
TerP has dual activity and is able to convert terpendole E (1) to
13-desoxyterpendole I (11) and paspaline (6) to 13-desoxypaxil-
line (7). Finally, the DGC+Q-3 strain was fed with paspaline (6)
and was shown to convert paspaline (6) to terpendole E (1) (Fig-
ure 4C), confirming that TerQ is a C11-hydroxylating enzyme.
TerQ Is a Key Enzyme in the Biosynthesis of Terpendole
E (1) and Other Terpendoles
To compare the substrate specificities of TerQ and PaxQ, we
constructed two PaxQ-expressing C. alba strains (DGC+paxQ-
3 and DGC+paxQ-5) in which all ter genes except terQ were
deleted and the terQ ORF was replaced with the paxQ ORF (Fig-
ure 3). TheDGC+paxQ-3 strain could metabolize 13-desoxypax-
illine (7) to paxilline (2) (Figure 4E) but could not metabolize
paspaline (6) to terpendole E (1) (Figure 4C), suggesting that
PaxQ and TerQ have different substrate specificities and that
TerQ is a key enzyme in the biosynthesis of terpendole E (1)
and its downstream metabolites in C. alba.
DISCUSSION
We propose a biosynthetic pathway for terpendoles (Figure 6).
The terpendole biosynthetic gene cluster is composed of seven9, December 21, 2012 ª2012 Elsevier Ltd All rights reserved 1613
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Figure 3. Manipulation of the Terpendole
Biosynthetic Gene Cluster
Genes with similarity to known indole-diterpene
biosynthetic genes are shaded. Marker genes are
shown as filled pentagons. Arrowheads are an-
nealing sites for the PCR primers used for analysis
of the terpendole biosynthetic gene cluster.
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Terpendole Biosynthetic Gene Clustergenes (Table S1; Figure 2A) and is similar to other indole-
diterpene biosynthetic gene clusters (Table S3), particularly for
lolitrem B (4), suggesting that the biosynthetic mechanism for
terpendoles and lolitrem B (4) are very similar. The terpendole
E (1) cluster lacks a gene for GGPPS (geranylgeranyl diphos-
phate synthase), and we could not isolate homologs of other
GGPPS genes (paxG, atmG, and ltmG) by using degenerate
PCR primers (data not shown). We therefore speculate that the
GGPPS gene for terpendole biosynthesis has low sequence
similarity to other GGPPS genes involved in indole-diterpene
biosynthesis. The terpendole biosynthetic gene cluster does
not contain a transcription factor gene (Table S1). Similarly, no
transcription factor gene has been found in gene clusters for
paxilline (2) and lolitrem B (4) (Saikia et al., 2008). In this study,
we used a fermentation medium FDY for terpendole production.
Terpendole production started within 1 day, and high-level
production was observed at 2 and 3 days of cultures (Figure 2).
Similar high-level terpendole production was also observed in
two additional fermentation media (YG and PD; data not shown).
These data suggest that regulation of terpendole production is
not strict.
Five of the seven genes in the terpendole biosynthetic cluster
are common to indole-diterpene biosynthesis. TerC, TerM, and
TerB are homologs of enzymes required for biosynthesis of
paspaline (6), the first recognized intermediate in indole-
diterpene biosynthesis. The mechanism of precursor cyclization
to paspaline (6) has not yet been elucidated. However, Pyr4,
a homolog of TerB, was recently shown to be a new terpene
cyclase for meroterpene biosynthesis (Itoh et al., 2010), suggest-
ing that TerB may also be a terpene cyclase for terpendole
biosynthesis.
TerP and TerQ are homologs of P450s involved in the down-
stream metabolism of paspaline. TerQ is a key enzyme involved
in terpendole E (1) biosynthesis. Homologs of TerQ create
structural diversity in the indole-diterpenes; for example, PaxQ
and AtmQ produce different products from the same substrate,
13-desoxypaxilline (7) (Nicholson et al., 2009). TerQ is uniquely
able to hydroxylate paspaline (6) at C11, and the presence of
11-OH enables creation of a C11-C12 epoxy structure (Figure 6)
by TerP. TerP converts terpendole E (1) to 13-desoxyterpendole I
(11), which is predicted to be an important intermediate in the
biosynthesis of terpendoles. We confirmed that 13-desoxyter-
pendole I (11) is produced from terpendole E (1) by TerP in
feeding experiments with a TerP-expressing strain. The C11-
C12 epoxy structure is also observed in lolitrem B (4) of N. lolii,1614 Chemistry & Biology 19, 1611–1619, December 21, 2012 ª2012 Elsevier Ltd All rights resuggesting that the lolitrem B (4) bio-
synthetic enzyme LtmQ also has C11-
hydroxylation activity. 13-Desoxypaxilline
(7) is a biosynthetic intermediate in
paxilline (2) and aflatrem (3) producers.However, in C. alba, this compound seems to be a shunt
metabolite.
Two of the seven terpendole biosynthetic enzymes are
specific to the terpendole producer (TerF and TerK) and the
lolitrem B (4) producer (LtmF and LtmK). LtmF and LtmK are
candidate enzymes for the conversion of terpendole I (8) to
30-prenylterpendole I (terpendole J), and for the conversion of
terpendole J to terpendole C (10), respectively (Young et al.,
2009), suggesting that TerF and TerK are also required for
conversion of terpendole I (8) to terpendole C (10).
Previous studies have indicated that paspaline (6) is a common
key biosynthetic intermediate of indole-diterpenes (Saikia et al.,
2008). Our data indicate that terpendole E (1), biosynthesized
from paspaline (6), is a key intermediate of terpendole biosyn-
thesis. We propose that there are at least two indole-diterpene
biosynthetic pathways (Figure 7). One, functional in C. alba,
converts paspaline (6) to 11-OH–containing compounds such
as terpendole E (1), which is used as a biosynthetic intermediate.
The alternative route, found in P. paxilli and A. flavus, instead
converts paspaline (6) to the C11-C12 double bond-containing
13-desoxypaxilline (7), which serves as an important bio-
synthetic intermediate. Terpendole E (1) is converted to 13-des-
oxyterpendole I (11) containing a C11-C12 epoxy structure.
Demethylation of C12 in the presence or absence of 11-OH
produces a C11-C12 epoxy structure and a C11-C12 double
bond, respectively. It appears that N. lolii also uses terpendole
E (1) or a terpendole E-like compound as an important interme-
diate because this fungus produces a terpendole E-like
compound, lolicine A (5), and lolitrem B (4) also has a C11-C12
epoxy structure. Lolitrem B (4) shows potent tremorgenic activity
(Gallagher et al., 1981), and production of this mycotoxin could
potentially be controlled by intervening at the C11-C12 epoxy
formation step. Our data suggest that the biosynthetic pathways
for indole-diterpenes may differ between Sordariomycetes
(C. alba, N. lolii, and E. festucae) and Eurotiomycetes (P. paxilli
and A. flavus). Interestingly, P. paxilli has an additional biosyn-
thetic gene predicted to encode an unknown membrane protein
(PaxA) that is proposed to function at postpaspaline steps
(Table S3) (Saikia et al., 2008). A. flavus also has a PaxA homolog
(AtmA) (Nicholson et al., 2009). Thus, PaxA homologs may have
functions specific to paxilline and aflatrem biosynthesis.
In the wild-type C. alba strain, terpendole E (1) accumulated
only transiently at early culture times (Figure 2B). Disruption
of the terP gene caused overproduction of terpendole E (1)
(Figure 2B). terP disruption blocks two points: conversion ofserved
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Figure 4. Analysis of the Terpendole Biosynthetic Pathway by Feeding Experiments
Each strain was fed with terpendole E (1) (A), 13-desoxyterpendole E (11) (B), paspaline (6) (C), a-PC-M6 (12) (D), and 13-desoxypaxilline (7) (E). Terpendoles were
detected by absorbance at 280 nm. ND, not detected. For further details, see Figure S1 and Table S2.
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Terpendole Biosynthetic Gene Clusterterpendole E (1) to 13-desoxyterpendole I (11) and conversion
of paspaline (6) to 13-desoxypaxilline (7) (Figure 6). Inhibition of
the latter step causes accumulation of paspaline (6) and its
conversion to terpendole E (1) by the action of TerQ, making
terP disruption a very efficient way to overproduce terpendole
E (1). C. alba also produces terpendoles that have ACAT (acyl-
CoA: cholesterol acyltransferase) inhibitory activity (Huang
et al., 1995a, 1995b; Tomoda et al., 1995) or tremorgenic activity
(Munday-Finch et al., 1997). Thus, pathway engineering of the
terpendole biosynthetic gene cluster will enable us to isolate
new terpendoles having highly potent biological activities.SIGNIFICANCE
Terpendole E, an indole-diterpene compound, is the first
natural product inhibitor of kinesin Eg5. However, terpen-
dole E production in vivo is unstable, and thus, further anal-
ysis of its action is difficult. Here, we isolated and analyzed
the terpendole E biosynthetic gene cluster, which revealed
that terpendole E is a key early intermediate in terpendole
biosynthesis, explaining its transient appearance. Terpen-
dole E was successfully overproduced by gene knockout
of the bispecific enzyme TerP. Importantly, terpendole E is
not produced during biosynthesis of indole-diterpenes in
distantly related fungi. We propose that indole-diterpene
biosynthetic pathways can be classified into two groups.Chemistry & Biology 19, 1611–161The isolated terpendole E biosynthetic gene cluster will be
an important tool in isolating new terpendole E analogs
with more potent biological activities.
EXPERIMENTAL PROCEDURES
Strains, Media, Culture, and Transformation
The terpendole E (1) producer Chaunopycnis alba RK99-F33 (Nakazawa et al.,
2003) was used as the parental strain. C. albawas grown on YGA plates (0.5%
yeast extract, 2% glucose, and 2% Bacto agar; Difco, Detroit, MI) or PDA
plates (3.9% potato dextrose agar; Difco), or in YG media (0.5% yeast extract
and 2% glucose), PD media (2.4% potato dextrose; Difco), or FDY media
(1.5% glucose, 1.5% soluble starch, 1% corn steep liquor, 1% dried yeast,
0.3% malt extract, 0.03% MgSO4,7H2O, 0.1% KH2PO4, and 0.1% agar [pH
6.0]) at 25C or 28C. C. alba was transformed by the Agrobacterium tumefa-
ciens-mediated transformation method (ATMT) (de Groot et al., 1998; Rho
et al., 2001) as described previously (Motoyama et al., 2008). A. tumefaciens
strain C58 was cultured with a conidial suspension of C. alba. Transformants
were selected by 500 mg/ml hygromycin B (Wako Pure Chemical, Osaka,
Japan) or 4 mg/ml geneticin (Wako). In subsequent cultures of C. alba
transformants, the appropriate selection reagents (200 mg/ml hygromycin B
or 1 mg/ml geneticin) were added as needed. Plasmids were amplified in
Escherichia coli DH5a (Sambrook et al., 1989). The paxilline (2) producer
Penicillium paxilli PN2013 was purchased from ATCC. P. paxilli was grown
on PDA or in PD. E. coli was grown in LB, and transformation was performed
by the standard method (Sambrook et al., 1989).
DNA Manipulations
Total DNA was extracted from C. alba and P. paxilli using the DNeasy
plant total DNA isolation kit (QIAGEN KK, Tokyo, Japan). PCR amplifications9, December 21, 2012 ª2012 Elsevier Ltd All rights reserved 1615
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Figure 5. TerQ Is Involved in Conversion of
Paspaline (6) to Terpendole E (1)
A terQ knockout strain (Q-10) accumulates pas-
paline (6) and 13-desoxypaxilline (7). A terP/terQ
double-knockout strain accumulates paspaline
(6). Recombinant strains were cultured in FDY for
1–3 days and cultures were analyzed by HPLC.
Terpendoles were detected by absorbance at
280 nm.
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Japan) and KOD Plus (Toyobo, Tokyo, Japan) or KOD FX (Toyobo) DNA
polymerases. KOD Plus is a proofreading DNA polymerase that was
used for plasmid construction, and KOD FX was used for routine PCR. The
PCR products were cloned by using the Zero Blunt TOPO PCR cloning kit
(Invitrogen, San Diego, CA) and sequenced, where necessary. The genome
walker universal kit (Takara Bio) was used for genome walking. The
sequencing reactions were performed with the BigDye Terminator version
3.1 cycle sequencing kit (Amersham-Pharmacia Biotech, Piscataway, NJ).
Reaction products were analyzed using an Applied Biosystems 3730xl
DNA analyzer (Perkin Elmer/Applied Biosystems, Foster City, CA). Nucleotide
and amino acid sequence data were analyzed by DNASIS-Mac software
(Hitachi Software Engineering, Tokyo, Japan). Open reading frames
were predicted by FGENESH and FGENESH+ software (Softberry, Mount
Kiscko, NY).
Construction of Recombinant Strains
The PCR primers used for plasmid construction are listed in Table S4.
terP disruptants were constructed as follows. The upstream sequence of
terP was amplified from the genomic DNA of C. alba by PCR using XhoI-
50terP-F and XbaI-50terP-R primers. The 1.0 kb fragment was gel purified,
digested with XhoI and XbaI, and gel purified (fragment 1). The hygromycin
B-resistance gene expression unit was amplified from pCSN45 (Motoyama
et al., 2005) by PCR by using MluI-HYG-F and XbaI-HYG-R primers. The
1.6 kb fragment was gel purified, digested withMluI and XbaI, and gel purified
(fragment 2). The downstream sequence of terP was amplified from the
genomic DNA of C. alba by PCRwith MluI-30terP-F and SseI-30terP-R primers.
The 1.0 kb fragment was gel purified, digested with MluI and SseI, and gel
purified (fragment 3). The vector sequence of pBI121 between the right border
and left border was amplified from pBI121 by PCR with XhoI-RB and SseI-LB
primers. The 8.7 kb fragment was gel purified, digested with XhoI and SseI,
and gel purified (fragment 4). The four fragments were ligated to yield a terP
disruption vector, pBI-terP::HPH. The A. tumefaciens strain transformed with
this plasmid was used for ATMT. terP disruptants were selected by PCR
with terP-check-F and terP-check-R primers, which hybridize just upstream
and just downstream of the deleted terP ORF, respectively. This primer set
can amplify 1.2 kb terP ORF from wild-type strains, the 1.6 kb hygromycin
B-resistance gene expression unit from terP disruptants, and both fragments
from ectopic transformants. terP disruptants express a truncated TerP peptide
(1–139). To exclude the effect of ectopic integrations, a number of knockout
strains were isolated.
terQ disruptants were constructed as follows. The upstream sequence of
terQ was amplified from the genomic DNA of C. alba by PCR using XhoI-
50terQ-F and XbaI-50terQ-R primers. The 1.0 kb fragment was gel purified,
digested with XhoI and XbaI, and gel purified (fragment 1). The hygromycin1616 Chemistry & Biology 19, 1611–1619, December 21, 2012 ª2012 Elsevier Ltd All rights reB-resistance gene expression unit was amplified
from pCSN45 by PCR by using MluI-HYG-F and
XbaI-HYG-R primers. The 1.6 kb fragment was
gel purified, digested with MluI and XbaI, and
gel purified (fragment 2). The downstream
sequence of terQ was amplified from the
genomic DNA of C. alba by PCR with MluI-
30terQ-F and SseI-30terQ-R primers. The 1.0 kb
fragment was gel purified, digested with MluI
and SseI, and gel purified (fragment 3). The vectorsequence of pBI121 between the right border and left border was amplified
from pBI121 by PCR with XhoI-RB and SseI-LB primers. The 8.7 kb fragment
was gel purified, digested with XhoI and SseI, and gel purified (fragment 4).
The four fragments were ligated to yield a terQ disruption vector, pBI-
terQ::HPH. The A. tumefaciens strain transformed with this plasmid was
used for ATMT. terQ disruptants were selected by PCR with terQ-check-F
and terQ-check-R primers, which hybridize just upstream and just down-
stream of terQ ORF, respectively. This primer set can amplify the 2.1 kb
terQ ORF from wild-type strains, the 1.6 kb hygromycin B-resistance gene
expression unit from terQ disruptants, and both fragments from ectopic
transformants. The Q-10 strain was selected as a terQ gene-disrupted
strain. To exclude the effect of ectopic integrations, Q-102, a second terQ
knockout strain, was constructed similarly by using pBI-terQ::
GEN (see next paragraph).
terP/terQ double-knockout strains were constructed as follows. The
upstream sequence of terQ was amplified from the genomic DNA of C. alba
by PCR using XhoI-50terQ-F and XbaI-50terQ-R primers. The 1.0 kb fragment
was gel purified, digested with XhoI and XbaI, and gel purified (fragment 1).
pUC-GEN, a plasmid containing a geneticin-resistance gene expression
unit, was constructed as follows. The geneticin-resistance gene ORF was
amplified from pBI121 by PCR with InFu-5NPTII and InFu-3NPTII primers
(fragment A). The 3.4 kb fragment containing the vector, the trpC promoter,
and the trpC terminator sequences was amplified from pUC-HYG (Motoyama
et al., 2008) by PCR by using InFu-PtrpC and InFu-TtrpC primers (fragment
B). Fragments A and B were connected by the InFusion system (Takara
Bio) to yield pUC-GEN. The geneticin-resistance gene expression unit was
amplified from pUC-GEN by PCR with MluI-HYG-F and XbaI-HYG-R primers.
The 1.4 kb fragment was gel purified, digested with MluI and XbaI, and gel
purified (fragment 2). The downstream sequence of terQ was amplified
from the genomic DNA of C. alba by PCR with MluI-30terQ-F and SseI-
30terQ(3kb)-R primers. The 3.0 kb fragment was gel purified, digested with
MluI and SseI, and gel purified (fragment 3). The vector sequence of
pBI121 between the right border and left border was amplified from pBI121
by PCR with XhoI-RB and SseI-LB primers. The 8.7 kb fragment was gel
purified, digested with XhoI and SseI, and gel purified (fragment 4). The four
fragments were ligated to yield a terQ disruption vector, pBI-terQ::GEN.
The A. tumefaciens strain transformed with this plasmid was used for
ATMT. terQ disruptants of the P-27 terP disruptant were selected by PCR
with terQ-check-F and terQ-check-R primers, which hybridize just upstream
and just downstream of the terQ ORF, respectively. This primer set can
amplify the 2.1 kb terQ ORF from wild-type strains, the 1.4 kb geneticin-resis-
tance gene expression unit from terQ disruptants, and both fragments from
ectopic transformants.
Gene cluster-deleted strains were constructed as follows. The 2.0 kb down-
stream sequence of terK was amplified from the genomic DNA of C. alba byserved
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Figure 6. Terpendole Biosynthetic Pathway
Seven gene products are proposed to be involved in the biosynthesis.
Paspaline (6) can be converted to a pathway intermediate terpendole E (1) or
to a shunt metabolite a-PC-M6 (12).
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Terpendole Biosynthetic Gene ClusterPCR using InFu-GC_LEFT-F and InFu-GC_LEFT-R primers (fragment 1).
The 1.4 kb geneticin-resistance gene expression unit was amplified from
pUC-GEN by PCR with 5HPH and 3HPH primers (fragment 2). The 2.0 kb
downstream sequence of terF was amplified from the genomic DNA of
C. alba by PCR with InFu-GC_RIGHT-F and InFu-GC_RIGHT-R primers
(fragment 3). The 6.9 kb vector sequence of pRI101 (Takara Bio) between
the right border and left border was amplified from pRI101 by PCR with
InFu-RB and InFu-LB primers (fragment 4). The four fragments were con-
nected by the InFusion system to yield a gene cluster deletion vector, pRI-
GC::GEN. The A. tumefaciens strain transformed with this plasmid was
used for ATMT. Gene cluster-deleted strains were selected by PCR with
GCoutside-check-F40 and GCoutside-check-R30-2 primers, which hybridize
just outside of the terK-downstream sequence and just outside of the
terF-downstream sequence. This primer set can amplify the 5.4 kb fragment
containing the terK-downstream sequence, the geneticin-resistance gene
expression unit, the terF-downstream sequence from the gene cluster-deleted
strains, and the 19.3 kb gene cluster from wild-type strains and ectopic
transformants.Chemistry & Biology 19, 1611–161A strain in which all of the ter genes except terQ were deleted was
constructed as follows. The 4.0 kb terQ gene was amplified from the
genomic DNA of C. alba by PCR using 5Q-1.5 kb and 3Q-0.5 kb-2 primers
(fragment 1). The 1.6 kb hygromycin B-resistance gene expression unit
was amplified from pCSN45 by PCR with InFu_3Q-5HPH and 3HPH primers
(fragment 2). A 10.9 kb fragment containing the 6.9 kb vector sequence of
pRI101, the 2.0 kb downstream sequence of terK, and the 2.0 kb down-
stream sequence of terF was amplified from pRI-GC::GEN by PCR with
InFu_5Q-GC_LEFT-R and InFu-GC_RIGHT-F primers (fragment 3). The
three fragments were connected by the InFusion system to yield a gene
cluster-replacing vector, pRI-GC::terQ-HYG. The A. tumefaciens strain
transformed with this plasmid was used for ATMT. Gene cluster-replaced
strains were selected by PCR with GCoutside-check-F40 and GCoutside-
check-R30-2 primers, which hybridize just outside of the terK-downstream
sequence and just outside of the terF-downstream sequence. This primer
set can amplify the 9.6 kb fragment containing the terK-downstream
sequence, the terQ gene, the hygromycin B-resistance gene expres-
sion unit, the terF-downstream sequence from the gene cluster-replaced
strains, and the 19.3 kb gene cluster from wild-type strains and ectopic
transformants.
A strain in which all of the ter genes except terP were deleted was con-
structed as follows. The 3.8 kb terP gene was amplified from the genomic
DNA of C. alba by PCR using 5P-1.5 kb and 3P-0.5 kb primers (fragment 1).
A 12.5 kb fragment containing the 6.9 kb vector sequence of pRI101, the 2.0
kb downstream sequence of terK, the 1.6 kb hygromycin B-resistance gene
expression unit, and the 2.0 kb downstream sequence of terF was amplified
from pRI-GC::terQ-HYG by PCR with InFu_5P-GC_LEFT-R and InFu_3P-
5HPH primers (fragment 2). The two fragments were connected by the
InFusion system to yield a gene cluster-replacing vector, pRI-GC::terP-HYG.
The A. tumefaciens strain transformed with this plasmid was used for ATMT.
Gene cluster-replaced strains were selected by PCR with GCoutside-check-
F40 and GCoutside-check-R30-2 primers, which hybridize just outside the
terK-downstream sequence and just outside the terF-downstream sequence.
This primer set can amplify the 9.4 kb fragment containing the terK-down-
stream sequence, the terP gene, the hygromycin B-resistance gene expres-
sion unit, the terF-downstream sequence from the gene cluster-replaced
strains, and the 19.3 kb gene cluster from wild-type strains and ectopic
transformants.
paxQ-introduced strains were constructed as follows. The 2.0 kb paxQORF
was amplified from the genomic DNA of Penicillium paxilli PN2013 by PCR
using InFu-PterQ_paxQ-F and InFu-TterQ_paxQ-R primers (fragment 1).
From pRI-GC::terQ-HYG, a 14.5 kb fragment without the terQ ORF was
amplified by PCR with InFu-PterQ-R and InFu-TterQ-F primers (fragment 2).
The two fragments were connected by the InFusion system to yield a paxQ-
introducing vector, pRI-GC::paxQ-HYG. The A. tumefaciens strain trans-
formed with this plasmid was used for ATMT. The DGC-2 strain was used as
the parental strain. paxQ-introduced strains were selected by PCR with
GCoutside-check-F40 and GCoutside-check-R30-2 primers, which hybridize
just outside the terK-downstream sequence and just outside the terF-down-
stream sequence. From the transformants in which paxQ is introduced by
homologous recombinations, this primer set can amplify the 9.6 kb fragment
containing the terK-downstream sequence, the paxQ gene expression unit,
the hygromycin B-resistance gene expression unit, and the terF-downstream
sequence. From wild-type strains and ectopic transformants, this primer set
can amplify the 5.4 kb fragment containing the terK-downstream sequence,
the geneticin-resistance gene expression unit, and the terF-downstream
sequence.
Preparation of Terpendoles
Terpendole E (1) was isolated from the wild-type strain or the P-27 strain.
Terpendoles I (8), C (10), and K (9) were isolated from the wild-type strain. 13-
Desoxypaxilline (7) and a-PC-M6 (12) were isolated from the Q-10 strain.
13-Desoxyterpendole I (11) was isolated from the wild-type strain or the
terpendole E-fed DGC+P-48 strain. Paxilline (2) was purchased from Sigma.
Production and Purification of Terpendoles
C. alba strains were cultured at 28C for 96 hr in a 30 l jar fermenter contain-
ing 15 l of the producing medium FDY. Cultures were treated with 2 volumes9, December 21, 2012 ª2012 Elsevier Ltd All rights reserved 1617
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Figure 7. Two Indole-Diterpene Biosyn-
thetic Pathways
Paspaline (6) is a common intermediate in both
pathways. Terpendole E (1) is proposed to be
a key biosynthetic intermediate of terpendole C
(10) and lolitrem B (4). 13-Desoxypaxilline (7) is
a key biosynthetic intermediate of paxilline (2) and
aflatrem (3).
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Terpendole Biosynthetic Gene Clusterof acetone, and the supernatant was concentrated in vacuo to remove
acetone. The resulting aqueous solution was extracted twice with ethyl
acetate. The organic layer was dried in vacuo. The dried material was sub-
jected to medium-pressure silica gel chromatography (CombiFlash, Teledyne
Isco, Lincoln, NE) using an 80 g RediSep column. The column was equili-
brated with chloroform and eluted with 1% methanol in chloroform. The
eluted fraction was dried in vacuo. The dried material was subjected to
preparative HPLC using a reverse phase column (PEGASIL ODS, 20 3
250 mm, Senshu Scientific, Tokyo, Japan) with a flow rate of 8 ml/min.
The gradient system was MeCN (solvent B) in H2O (solvent A): 20% to
80% B from 0 to 10 min, 80% to 100% B from 10 to 20 min, and 100% B
from 20 to 60 min.
Alternatively, C. alba strains were cultured at 28C in cylindrical flasks con-
taining 70 ml of the producing medium. Terpendoles were purified similarly
without the medium-pressure gel chromatography purification step.
Analysis of Terpendoles
Terpendoles were analyzed by HPLC or LC/MS. HPLC was performed using
a reverse phase column (ODS-3, 4.6 3 250 mm, GL Sciences, Tokyo, Japan)
with a flow rate of 1 ml/min. The gradient system was MeCN (solvent B)
in H2O (solvent A): 20% to 80% B from 0 to 10 min, 80% to 100% B
from 10 to 20 min, 100% B from 20 to 50 min, and re-equilibration with1618 Chemistry & Biology 19, 1611–1619, December 21, 2012 ª2012 Elsevier Ltd All rights re20% B from 50 to 60 min. LC/MS was carried
out using an Applied Biosystems Q Trap LC/
MS/MS system with a reverse phase column
(XTerra MS C18, 2.1 3 150 mm, Waters, Tokyo,
Japan) at a flow rate of 0.2 ml/min. The gradient
system was MeCN (solvent B) in 0.05%
acetic acid-H2O (solvent A): 5% to 95% B
from 0 to 30 min, 95% B from 30 to 50 min,
and re-equilibration with 5% B from 50 to
60 min. Positive-ion electrospray ionization (ESI)
was used for the detection of terpendoles.
Conditions for MS were an ion spray voltage of
5.0 kV, a curtain gas pressure at 15 psi, a nebu-
lizer gas pressure at 40 psi, an auxiliary gas
pressure at 50 psi, and an ion source temperature
of 400C.
Identification of Terpendoles
The high-resolution mass spectra were recorded
on a JEOL EI-MS (JMS-SX102A). The 1H-, 13C-,
and 2D NMR spectra were produced using
a Bruker DRX-500 (500 MHz) spectrometer.
Feeding Experiments
C. alba strains were cultured for 24 hr at 28C
in cylindrical flasks containing 70 ml of the
producing medium FDY. A sample of 0.5 ml
culture was then mixed with 0.5 ml 0.1% agar
solution and 1.67 ml 30 mM terpendoles (final
concentration of 50 mM) and the mixture was
incubated for 24 hr at 28C. The culture was
treated with 2 volumes of acetone and the
supernatant was concentrated under N2 flow toremove acetone. The resulting aqueous solution was extracted with ethyl
acetate twice. The organic layer was dried under N2 flow. The dry material
was dissolved in 200 ml of MeCN and analyzed by LC/MS.
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